<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - [REDACTED]</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Problems</a></li><li><a href="#id6">Vital Signs</a></li><li><a href="#id7">Encounters</a></li><li><a href="#id8">Assessments</a></li><li><a href="#id9">Plan Of Treatment</a></li><li><a href="#id10">Progress Notes</a></li><li><a href="#id11">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><table width="100%" border="1"><thead><tr><th>Allergen (clinical drug ingredient)</th><th>Drug/Non Drug Allergy documented on EMR</th><th>Reaction</th><th>Allergy Type</th><th>Onset Date</th><th>Status</th></tr></thead><tbody><tr><td ID="allergy1"/><td>Iodine</td><td ID="reaction1">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr><tr><td ID="allergy2">Shellfish (FN)</td><td>Shellfish-derived Products</td><td ID="reaction2">Unknown</td><td>Drug Allergy</td><td/><td>Active</td></tr></tbody></table></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>1 month f/u</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Envarsus XR 4 MG</td><td ID="instruction1">one tablet Orally Daily for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Albuterol Sulfate HFA 108 (90 Base) MCG/ACT</td><td ID="instruction2">1 puff as needed Inhalation Every 6 hours</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Nitroglycerin 0.4 MG</td><td ID="instruction3">one tablet every 5 min. x 3 prn CP Sublingual As needed</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Albuterol Sulfate (2.5 MG/3ML) 0.083%</td><td ID="instruction4">3 mL as needed Inhalation Three times per day for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication5">EQ Aspirin Adult Low Dose 81 MG</td><td ID="instruction5">Take 1 tablet by mouth once daily for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">True Metrix Meter -</td><td ID="instruction6">as directed dermally TID for 90 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication7">True metrix lancets lancet</td><td ID="instruction7">1 lancet dermally three times a day for 90 days</td><td ID="medication7notes">*Reorder from Medispan for eRx and Interaction Alerts*</td><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication8">True Metrix Blood Glucose Test -</td><td ID="instruction8">as directed sq TID for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication9">traMADol HCl 50 MG</td><td ID="instruction9">1 tablet as needed Orally Twice a day FOR NON-ACUTE PAIN for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication10">ReliOn Pen Needles 31G X 8 MM</td><td ID="instruction10">USE 1  THREE TIMES DAILY BEFORE MEAL(S) for 100</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">predniSONE 2.5 MG</td><td ID="instruction11">TAKE 1 TABLET BY MOUTH ONCE DAILY Oral for 30 Days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">Ondansetron 8 MG</td><td ID="instruction12">1 tablet on the tongue and allow to dissolve Orally twice a day for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication13">Metoprolol Succinate 25 MG</td><td ID="instruction13">1/2 tab Orally Twice a day</td><td ID="medication13notes">*Reorder from Medispan for eRx and Interaction Alerts*</td><td/><td/><td>Active</td></tr><tr><td ID="medication14">Pantoprazole Sodium 40 MG</td><td ID="instruction14">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication15">Montelukast Sodium 10 MG</td><td ID="instruction15">one tablet Orally daily for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication16">Myfortic 180 MG</td><td ID="instruction16">1 tablet Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication17">Latanoprost 0.005 %</td><td ID="instruction17">1 drop into affected eye in the evening Ophthalmic Once a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication18">Lyrica 75 MG</td><td ID="instruction18">one capsule Orally twice a day for 30 days</td><td/><td>[REDACTED]</td><td/><td>Active</td></tr><tr><td ID="medication19">Atorvastatin Calcium 80 MG</td><td ID="instruction19">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication20">Gabapentin 300 MG</td><td ID="instruction20">Take 1 capsule by mouth once daily for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication21">Trulicity 1.5 MG/0.5ML</td><td ID="instruction21">as directed Subcutaneous weekly for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication22">Lantus SoloStar 100 UNIT/ML</td><td ID="instruction22">16-20 Units Subcutaneous Daily for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication23">NovoLOG Mix 70/30 FlexPen (70-30) 100 UNIT/ML</td><td ID="instruction23">10-20 units by sliding scale Subcutaneous twice a day for 30 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication24">Folic Acid 1 MG</td><td ID="instruction24">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication25">Fluticasone-Salmeterol 113-14 MCG/ACT</td><td ID="instruction25">1 puff Inhalation Twice a day for 30 days</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Tobacco Use:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th><th>Date</th></tr></thead><tbody><tr><td ID="smokingStatus1">Details (start date - stop date)</td><td>Never Smoker</td><td>NA - NA</td></tr></tbody></table><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table><span class="content_span">Tobacco Use/Smoking</span><table ID="socialhistorynotes" width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Tobacco use:</td><td>nonsmoker</td><td/></tr></tbody></table><span class="content_span">Alcohol Screen (Audit-C)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>Yes</td><td/></tr><tr><td>How often did you have a drink containing alcohol in the past year?</td><td>Monthly or less (1 point)</td><td/></tr><tr><td>How many drinks did you have on a typical day when you were drinking in the past year?</td><td>1 or 2 drinks (0 point)</td><td/></tr><tr><td>How often did you have 6 or more drinks on one occasion in the past year?</td><td>Never (0 point)</td><td/></tr><tr><td>Points</td><td>1</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">Problems</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>SNOMED Code</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td>191819002</td><td ID="Problem1">Continuous opioid dependence (F11.20)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr><tr><td>Problem</td><td>191611001</td><td ID="Problem2">Moderate episode of recurrent major depressive disorder (F33.1)</td><td/><td>Active</td><td>confirmed</td><td/><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>97.0 degrees Fahrenheit</td><td>[REDACTED]</td></tr><tr><th ID="vital2">Heart Rate</th><td>92 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital3">Respiratory Rate</th><td>16 /min</td><td>[REDACTED]</td></tr><tr><th ID="vital4">Height</th><td>65.5 in</td><td>[REDACTED]</td></tr><tr><th ID="vital5">Weight</th><td>244.8 lbs</td><td>[REDACTED]</td></tr><tr><th ID="vital6">BMI</th><td>40.11 kg/m2</td><td>[REDACTED]</td></tr><tr><th ID="vital7">Oximetry</th><td>95 %</td><td>[REDACTED]</td></tr><tr><th ID="vital8">Weight-kg</th><td>111.04 kg</td><td>[REDACTED]</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Temple Terrace</td><td>[REDACTED][REDACTED]</td><td>[REDACTED]</td><td>[REDACTED]</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease I13.0 ; CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min N18.2 ; Chronic diastolic congestive heart failure I50.32 ; Coronary artery disease of native artery of native heart with stable angina pectoris I25.118 ; PAF (paroxysmal atrial fibrillation) I48.0 ; Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22 ; Type 2 diabetes mellitus with hyperglycemia E11.65 ; Type 2 diabetes mellitus with other specified complication E11.69 ; Hypercholesterolemia E78.00 ; Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema E11.319 ; Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene E11.51 ; Type 2 diabetes mellitus with diabetic polyneuropathy E11.42 ; Type 2 diabetes mellitus with other circulatory complications E11.59 ; Type 2 diabetes mellitus with diabetic nephropathy E11.21 ; S/P kidney transplant Z94.0 ; [REDACTED] and hemiparesis following cerebral infarction affecting left non-dominant side I69.354 ; Other thrombophilia D68.69 ; Chronic obstructive pulmonary disease, unspecified COPD type J44.9 ; Obstructive sleep apnea (adult) (pediatric) G47.33 ; Opioid dependence with opioid-induced mood disorder F11.24 ; Chronic GERD K21.9 ; Moderate episode of recurrent major depressive disorder F33.1 ; Non-radiographic axial spondyloarthritis of lumbosacral region M45.A7 ; Lumbar spondylosis with myelopathy M47.16 ; Environmental allergies Z91.09 ; Immunodeficiency due to conditions classified elsewhere D84.81 ; Continuous opioid dependence F11.20 ; Stenosis of other vascular prosthetic devices, implants and grafts, initial encounter T82.858A ; Chronic pain syndrome G89.4 ; Dependence on other enabling machines and devices Z99.89 ; Long term (current) use of insulin Z79.4 ; Morbid obesity E66.01 and Body mass index (BMI) of 38.0-38.9 in adult Z68.38</td></tr></tbody></table></div><h3><a name="id8" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">[REDACTED]</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease (ICD-10 - I13.0)</td><td/><td>Controlling your high blood pressure is a lifelong commitment. You will always need to monitor your weight, make healthy food choices, exercise, learn to cope with stress, avoid smoking, and limit your alcohol intake. We will monitor your blood pressure going forward</td><td/></tr><tr><td ID="ref2">[REDACTED]</td><td>CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min (ICD-10 - N18.2)</td><td>GFR 62</td><td><p/><p>Avoid nephrotoxic agents.</p><p>Monitor BP at home: keep a log and call &amp; call office if SBP&gt;140</p><p>or DBP &gt;90.</p></td><td/></tr><tr><td ID="ref3">[REDACTED]</td><td>Chronic diastolic congestive heart failure (ICD-10 - I50.32)</td><td/><td><p>Patient to continue current medications and cardio recommendations/meds, monitor fluids: in and out.  Follow a low salt diet.  Increase ambulation and light exercise. </p><p>Continue with current ACE/ARB and beta blocker. </p><p>Patient instructed to call or return to clinic before appointment if condition worsens. VU</p></td><td/></tr><tr><td ID="ref4">[REDACTED]</td><td>Coronary artery disease of native artery of native heart with stable angina pectoris (ICD-10 - I25.118)</td><td/><td><p>Maintain good control of BP and Lipids, </p><p>Monitor for symptoms.</p></td><td/></tr><tr><td ID="ref5">[REDACTED]</td><td>PAF (paroxysmal atrial fibrillation) (ICD-10 - I48.0)</td><td/><td>No anticoagulants secondary to post-op status.  No clinical recurrence. Monitor s/s going forward. Cardiology followup. </td><td/></tr><tr><td ID="ref6">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td/><td><p> Patient is followed by Endocrinology ([REDACTED]) to regulate his Diabetic Medications; last A1C was 11.6. </p><p>Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml</p><p>Lab ordered for A1C, GFR and urine proteins.</p></td><td/></tr><tr><td ID="ref7">[REDACTED]</td><td>Type 2 diabetes mellitus with hyperglycemia (ICD-10 - E11.65)</td><td>A1C 9.5</td><td/><td/></tr><tr><td ID="ref8">[REDACTED]</td><td>Type 2 diabetes mellitus with other specified complication (ICD-10 - E11.69)</td><td>Hypercholesterolemia</td><td><p> Patient is followed by Endocrinology ([REDACTED]) to regulate his Diabetic Medications; last A1C was 11.6.</p><p>Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml</p><p>Lab ordered for A1C, GFR and urine proteins.</p></td><td/></tr><tr><td ID="ref9">[REDACTED]</td><td>Hypercholesterolemia (ICD-10 - E78.00)</td><td/><td>Low cholesterol / high fiber diet. Monitor.</td><td/></tr><tr><td ID="ref10">[REDACTED]</td><td>Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema (ICD-10 - E11.319)</td><td/><td><p>Follows by Opthalmologist</p><p>Monitor opthamologic signs and symptoms retinopathy present as a complication of diabetes.</p></td><td/></tr><tr><td ID="ref11">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene (ICD-10 - E11.51)</td><td/><td><p> Patient is followed by Endocrinology ([REDACTED]) to regulate his Diabetic Medications; last A1C was 11.6.</p><p>Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml</p><p>Lab ordered for A1C, GFR and urine proteins.</p></td><td/></tr><tr><td ID="ref12">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic polyneuropathy (ICD-10 - E11.42)</td><td/><td>Monitor neurologic signs and symptoms going forward - neuropathy present as a complication of diabetes.</td><td/></tr><tr><td ID="ref13">[REDACTED]</td><td>Type 2 diabetes mellitus with other circulatory complications (ICD-10 - E11.59)</td><td/><td>Followed by Endocrinologist</td><td/></tr><tr><td ID="ref14">[REDACTED]</td><td>Type 2 diabetes mellitus with diabetic nephropathy (ICD-10 - E11.21)</td><td/><td>Followed by [REDACTED]</td><td/></tr><tr><td ID="ref15">[REDACTED]</td><td>S/P kidney transplant (ICD-10 - Z94.0)</td><td/><td>Followed by Nephrologist</td><td/></tr><tr><td ID="ref16">[REDACTED]</td><td>Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side (ICD-10 - I69.354)</td><td/><td><p>Control comorbid conditions. </p><p>Patient is to maintain normal blood pressure and blood glucose readings if diabetic. </p><p>Stressed the importance of medication adherence.</p><p>Follow a low fat diet and continue to monitor for signs and symptoms as discussed.</p></td><td/></tr><tr><td ID="ref17">[REDACTED]</td><td>Other thrombophilia (ICD-10 - D68.69)</td><td/><td><p>linked to AFIB, continue aspirin therapy. </p><p>WIll continue monitor </p></td><td/></tr><tr><td ID="ref18">[REDACTED]</td><td>Chronic obstructive pulmonary disease, unspecified COPD type (ICD-10 - J44.9)</td><td/><td>If you smoke, quit.  Also avoid air pollution, chemical fumes, dust, and secondhand smoke. Do activities slowly and find simple ways to do daily activities, such as cooking or cleaning. Call your doctor if your symptoms are getting worse or if you have signs of an infection, such as fever.</td><td/></tr><tr><td ID="ref19">[REDACTED]</td><td>Obstructive sleep apnea (adult) (pediatric) (ICD-10 - G47.33)</td><td/><td><p>Avoid sedatives/hypnotics and alcohol before going to bed. </p><p>Stress importance of ongoing CPAP compliance. </p></td><td/></tr><tr><td ID="ref20">[REDACTED]</td><td>Opioid dependence with opioid-induced mood disorder (ICD-10 - F11.24)</td><td/><td>Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high risk situations; Use has resulted in a reduction of recreational, social and or occupational activities; Note: Physical Dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/ or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy.</td><td/></tr><tr><td ID="ref21">[REDACTED]</td><td>Chronic GERD (ICD-10 - K21.9)</td><td/><td><p/><p> </p><p>  </p><p>  Watch alcohol, eating too close to bedtime, chocolate,</p><p>  caffeine, greasy, spicy, and acidic foods. Monitor symptoms.</p><p>  </p><p> </p></td><td/></tr><tr><td ID="ref22">[REDACTED]</td><td>Moderate episode of recurrent major depressive disorder (ICD-10 - F33.1)</td><td/><td>Exercise regularly, eat healthy, and get plenty of sleep. Encourage yourself and be patient. Monitor Symptoms.</td><td/></tr><tr><td ID="ref23">[REDACTED]</td><td>Non-radiographic axial spondyloarthritis of lumbosacral region (ICD-10 - M45.A7)</td><td/><td>Reviewed appropriate OTC's, massage, and ice or heat as needed. Correct posture when sitting and during activities; Stay active and do not forget to stretch. Monitor Symptoms.</td><td/></tr><tr><td ID="ref24">[REDACTED]</td><td>Lumbar spondylosis with myelopathy (ICD-10 - M47.16)</td><td/><td>Reviewed appropriate OTC's, massage, and ice or heat as needed. Correct posture when sitting and during activities; Stay active and do not forget to stretch. Monitor Symptoms.</td><td/></tr><tr><td ID="ref25">[REDACTED]</td><td>Environmental allergies (ICD-10 - Z91.09)</td><td/><td><p/><p> </p><p>  </p><p>  Avoid things you are allergic to by: keeping windows closed</p><p>  during high-pollen season, showering before bed to wash off allergens and</p><p>  using dust and mite-proof bedding and mattress covers. Monitor symptoms.</p><p>  </p><p> </p></td><td/></tr><tr><td ID="ref26">[REDACTED]</td><td>Immunodeficiency due to conditions classified elsewhere (ICD-10 - D84.81)</td><td/><td><p/><p> </p><p>  </p><p>  Chronic disease present - High risk patient. Monitor</p><p>  closely for occult infections going forward.  </p><p>  </p><p> </p></td><td/></tr><tr><td ID="ref27">[REDACTED]</td><td>Continuous opioid dependence (ICD-10 - F11.20)</td><td/><td>Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high risk situations; Use has resulted in a reduction of recreational, social and or occupational activities; Note: Physical Dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/ or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy.</td><td/></tr><tr><td ID="ref28">[REDACTED]</td><td>Stenosis of other vascular prosthetic devices, implants and grafts, initial encounter (ICD-10 - T82.858A)</td><td/><td>Monitor for changes</td><td/></tr><tr><td ID="ref29">[REDACTED]</td><td>Chronic pain syndrome (ICD-10 - G89.4)</td><td/><td>Followed by PM</td><td/></tr><tr><td ID="ref30">[REDACTED]</td><td>Dependence on other enabling machines and devices (ICD-10 - Z99.89)</td><td/><td>Safety precautions discussed and advised the patient to be aware of their surroundings</td><td/></tr><tr><td ID="ref31">[REDACTED]</td><td>Long term (current) use of insulin (ICD-10 - Z79.4)</td><td/><td>Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml</td><td/></tr><tr><td ID="ref32">[REDACTED]</td><td>Morbid obesity (ICD-10 - E66.01)</td><td/><td>Encouraged and stressed importance of diet and physical activity to improve BMI and overall health.  Discussed obtaining goal BMI through diet and exercise program.</td><td/></tr><tr><td ID="ref33">[REDACTED]</td><td>Body mass index (BMI) of 38.0-38.9 in adult (ICD-10 - Z68.38)</td><td/><td>Encouraged and stressed importance of diet and physical activity to improve BMI and overall health.  Discussed obtaining goal BMI through diet and exercise program.</td><td/></tr><tr><td ID="ref34">[REDACTED]</td><td>Other</td><td/><td>Advised to keep appt as scheduled</td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Nitroglycerin 0.4 MG</td><td>one tablet every 5 min. x 3 prn CP Sublingual As needed</td><td/><td/><td/></tr><tr><td ID="potMeds2">Metoprolol Succinate 25 MG</td><td>1/2 tab Orally Twice a day</td><td/><td/><td>*Reorder from Medispan for eRx and Interaction Alerts*</td></tr><tr><td ID="potMeds3">Pantoprazole Sodium 40 MG</td><td>1 tablet Orally Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds4">Montelukast Sodium 10 MG</td><td>one tablet Orally daily for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds5">Latanoprost 0.005 %</td><td>1 drop into affected eye in the evening Ophthalmic Once a day for 30 days</td><td/><td/><td/></tr><tr><td ID="potMeds6">Atorvastatin Calcium 80 MG</td><td>1 tablet Orally Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds7">Trulicity 1.5 MG/0.5ML</td><td>as directed Subcutaneous weekly for 30 days</td><td/><td/><td/></tr><tr><td ID="potMeds8">Lantus SoloStar 100 UNIT/ML</td><td>16-20 Units Subcutaneous Daily for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds9">NovoLOG Mix 70/30 FlexPen (70-30) 100 UNIT/ML</td><td>10-20 units by sliding scale Subcutaneous twice a day for 30 days</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</td><td>Controlling your high blood pressure is a lifelong commitment. You will always need to monitor your weight, make healthy food choices, exercise, learn to cope with stress, avoid smoking, and limit your alcohol intake. We will monitor your blood pressure going forward</td></tr><tr><td ID="instructionpot2">CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min</td><td><p/><p>Avoid nephrotoxic agents.</p><p>Monitor BP at home: keep a log and call &amp; call office if SBP&gt;140</p><p>or DBP &gt;90.</p></td></tr><tr><td ID="instructionpot3">Chronic diastolic congestive heart failure</td><td><p>Patient to continue current medications and cardio recommendations/meds, monitor fluids: in and out.  Follow a low salt diet.  Increase ambulation and light exercise. </p><p>Continue with current ACE/ARB and beta blocker. </p><p>Patient instructed to call or return to clinic before appointment if condition worsens. VU</p></td></tr><tr><td ID="instructionpot4">Coronary artery disease of native artery of native heart with stable angina pectoris</td><td><p>Maintain good control of BP and Lipids, </p><p>Monitor for symptoms.</p></td></tr><tr><td ID="instructionpot5">PAF (paroxysmal atrial fibrillation)</td><td>No anticoagulants secondary to post-op status.  No clinical recurrence. Monitor s/s going forward. Cardiology followup. </td></tr><tr><td ID="instructionpot6">Type 2 diabetes mellitus with diabetic chronic kidney disease</td><td><p> Patient is followed by Endocrinology ([REDACTED]) to regulate his Diabetic Medications; last A1C was 11.6. </p><p>Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml</p><p>Lab ordered for A1C, GFR and urine proteins.</p></td></tr><tr><td ID="instructionpot7">Type 2 diabetes mellitus with other specified complication</td><td><p> Patient is followed by Endocrinology ([REDACTED]) to regulate his Diabetic Medications; last A1C was 11.6.</p><p>Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml</p><p>Lab ordered for A1C, GFR and urine proteins.</p></td></tr><tr><td ID="instructionpot8">Hypercholesterolemia</td><td>Low cholesterol / high fiber diet. Monitor.</td></tr><tr><td ID="instructionpot9">Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema</td><td><p>Follows by Opthalmologist</p><p>Monitor opthamologic signs and symptoms retinopathy present as a complication of diabetes.</p></td></tr><tr><td ID="instructionpot10">Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene</td><td><p> Patient is followed by Endocrinology ([REDACTED]) to regulate his Diabetic Medications; last A1C was 11.6.</p><p>Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml</p><p>Lab ordered for A1C, GFR and urine proteins.</p></td></tr><tr><td ID="instructionpot11">Type 2 diabetes mellitus with diabetic polyneuropathy</td><td>Monitor neurologic signs and symptoms going forward - neuropathy present as a complication of diabetes.</td></tr><tr><td ID="instructionpot12">Type 2 diabetes mellitus with other circulatory complications</td><td>Followed by Endocrinologist</td></tr><tr><td ID="instructionpot13">Type 2 diabetes mellitus with diabetic nephropathy</td><td>Followed by Nephrologist</td></tr><tr><td ID="instructionpot14">S/P kidney transplant</td><td>Followed by Nephrologist</td></tr><tr><td ID="instructionpot15">Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side</td><td><p>Control comorbid conditions. </p><p>Patient is to maintain normal blood pressure and blood glucose readings if diabetic. </p><p>Stressed the importance of medication adherence.</p><p>Follow a low fat diet and continue to monitor for signs and symptoms as discussed.</p></td></tr><tr><td ID="instructionpot16">Other thrombophilia</td><td><p>linked to AFIB, continue aspirin therapy. </p><p>WIll continue monitor </p></td></tr><tr><td ID="instructionpot17">Chronic obstructive pulmonary disease, unspecified COPD type</td><td>If you smoke, quit.  Also avoid air pollution, chemical fumes, dust, and secondhand smoke. Do activities slowly and find simple ways to do daily activities, such as cooking or cleaning. Call your doctor if your symptoms are getting worse or if you have signs of an infection, such as fever.</td></tr><tr><td ID="instructionpot18">Obstructive sleep apnea (adult) (pediatric)</td><td><p>Avoid sedatives/hypnotics and alcohol before going to bed. </p><p>Stress importance of ongoing CPAP compliance. </p></td></tr><tr><td ID="instructionpot19">Opioid dependence with opioid-induced mood disorder</td><td>Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high risk situations; Use has resulted in a reduction of recreational, social and or occupational activities; Note: Physical Dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/ or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy.</td></tr><tr><td ID="instructionpot20">Chronic GERD</td><td><p/><p> </p><p>  </p><p>  Watch alcohol, eating too close to bedtime, chocolate,</p><p>  caffeine, greasy, spicy, and acidic foods. Monitor symptoms.</p><p>  </p><p> </p></td></tr><tr><td ID="instructionpot21">Moderate episode of recurrent major depressive disorder</td><td>Exercise regularly, eat healthy, and get plenty of sleep. Encourage yourself and be patient. Monitor Symptoms.</td></tr><tr><td ID="instructionpot22">Non-radiographic axial spondyloarthritis of lumbosacral region</td><td>Reviewed appropriate OTC's, massage, and ice or heat as needed. Correct posture when sitting and during activities; Stay active and do not forget to stretch. Monitor Symptoms.</td></tr><tr><td ID="instructionpot23">Lumbar spondylosis with myelopathy</td><td>Reviewed appropriate OTC's, massage, and ice or heat as needed. Correct posture when sitting and during activities; Stay active and do not forget to stretch. Monitor Symptoms.</td></tr><tr><td ID="instructionpot24">Environmental allergies</td><td><p/><p> </p><p>  </p><p>  Avoid things you are allergic to by: keeping windows closed</p><p>  during high-pollen season, showering before bed to wash off allergens and</p><p>  using dust and mite-proof bedding and mattress covers. Monitor symptoms.</p><p>  </p><p> </p></td></tr><tr><td ID="instructionpot25">Immunodeficiency due to conditions classified elsewhere</td><td><p/><p> </p><p>  </p><p>  Chronic disease present - High risk patient. Monitor</p><p>  closely for occult infections going forward.  </p><p>  </p><p> </p></td></tr><tr><td ID="instructionpot26">Continuous opioid dependence</td><td>Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high risk situations; Use has resulted in a reduction of recreational, social and or occupational activities; Note: Physical Dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/ or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy.</td></tr><tr><td ID="instructionpot27">Stenosis of other vascular prosthetic devices, implants and grafts, initial encounter</td><td>Monitor for changes</td></tr><tr><td ID="instructionpot28">Chronic pain syndrome</td><td>Followed by PM</td></tr><tr><td ID="instructionpot29">Dependence on other enabling machines and devices</td><td>Safety precautions discussed and advised the patient to be aware of their surroundings</td></tr><tr><td ID="instructionpot30">Long term (current) use of insulin</td><td>Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml</td></tr><tr><td ID="instructionpot31">Morbid obesity</td><td>Encouraged and stressed importance of diet and physical activity to improve BMI and overall health.  Discussed obtaining goal BMI through diet and exercise program.</td></tr><tr><td ID="instructionpot32">Body mass index (BMI) of 38.0-38.9 in adult</td><td>Encouraged and stressed importance of diet and physical activity to improve BMI and overall health.  Discussed obtaining goal BMI through diet and exercise program.</td></tr><tr><td ID="instructionpot33">Other</td><td>Advised to keep appt as scheduled</td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 4 Weeks, Reason: Labs 1 week before office visit</td></tr><tr><td ID="futureAppt1">Provider Name:[REDACTED], [REDACTED] 10:45:00 AM, [REDACTED][REDACTED]-1161, [REDACTED]</td></tr><tr><td ID="futureAppt2">Provider Name:[REDACTED], [REDACTED] 11:15:00 AM, [REDACTED][REDACTED], [REDACTED]</td></tr><tr><td ID="futureAppt3">Provider Name:[REDACTED], [REDACTED] 01:00:00 PM, [REDACTED]-1161, [REDACTED]</td></tr></tbody></table></div><h3><a name="id10" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>[REDACTED] <span class="bold">DOB:</span> [REDACTED] ([REDACTED] M) <span class="bold">Acc No.</span> 253404 <span class="bold">DOS:</span> [REDACTED]</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>[REDACTED]<br/><span class="bold">Account Number: </span>253404</td><td align="right"><span class="bold">Provider: </span>[REDACTED], ARNP, FNP-C</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>[REDACTED]<span class="bold">   Age: </span>47 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td><span class="bold">Phone: </span>[REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Address: </span>[REDACTED][REDACTED][REDACTED]</td></tr><tr><td colspan="2"><span class="bold">Pcp: </span>[REDACTED]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1 month f/u</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">[REDACTED]</span>: <br/>      Patient is here for [REDACTED] male who comes into the office accompanied by mother for a f/up visit and monitoring. Pt does not know all his medications; mother in charge of medications. Mother in the room, but most of the time she is on her phone and is not paying attention to her son's medical care.<br/><span class="bold"/>HTN; on Metoprolol 25mg 1/2 tab BID, Nitroglycerine 0.4mg sublingual prn. Patient seen by Cardiologist [REDACTED]; pt stated "the Dr did an EKG at the office and he told me that my heart is good"; next f/up [REDACTED].<br/>Noted B/P [REDACTED] 100/60; pt stated "my B/P at home is usually low; this morning it was 92/71 after I took my medication; it usually runns low; that is the reason sometimes I do not take the B/P medication" Patient did not bring his B/P log. Advised to keep a log and to bring it next office<br/>Patient is not on any Cardiac distress, denies any SOB, chest pain or chest pressure.<br/><span class="content_span">Recommended to Monitor BP at home: keep a log and call &amp; call office if SBP&gt;140or DBP &gt;90.</span>CAD s/p MI/ STENT; denies any SOB, CP, or chest pressure<br/>PAF; on Metoprolol Succ 25mg, Low Na diet<br/>CVA WITH LEFT SIDED WEAKNESS; Instructed on fall precautions and on change of positions<br/>ESRD; S/P RENAL TRANSPLANT, patient continues to follow up regularly with Nephrologist at TGH Transplant Medicine. Next appt on [REDACTED].<br/>HYPERCHOLESTEROLEMIA; pt on Atorvastatin 80mg<br/>OSA monitor for change<br/>GERD; avoid irritant foods and continue Tx<br/>T2DM; pt is followed by Endocrinology ([REDACTED]) to regulate his Diabetic Medications; last A1C was 11.6. Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml. Patient has f/up appt [REDACTED].<br/>Chronic Lower back pain; pt stated " I saw PM Dr last week and he gave me 6 injections to my lower back area"<br/>Patient has not done any of his labs<br/><content>Patientmedication has been reviewed and does not report any side effects.<content><br/>Patients current medication were reviewed, andRefills given as in chart.,<br/>Patient does not complain of any shortness ofbreath or chest pain.</content></content>. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General / Constitutional</span>: <br/>      Fatigue denies. Fever denies. Headache denies. Lightheadedness denies. Night sweats denies.   <br/>   <span class="Underline">Allergy / Immunology</span>: <br/>      Congestion denies. Cough denies.   <br/>   <span class="Underline">ENT</span>: <br/>      Decreased hearing denies. Decreased sense of smell denies. Difficulty in swallowing denies. Ear pain denies. Nasal congestion denies.   <br/>   <span class="Underline">Endocrine</span>: <br/>      Dizziness denies. Excessive sweating denies. Excessive thirst denies. Frequent urination denies. Heat intolerance denies.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Chest pain denies. Chest pain at rest denies. Claudication denies. Dizziness denies. Dyspnea on exertion denies.   <br/>   <span class="Underline">Gastrointestinal</span>: <br/>      Abdominal pain denies. Blood in stool denies. Change in bowel habits denies. Constipation denies. Decreased appetite denies. Diarrhea denies.   <br/>   <span class="Underline">Hematology</span>: <br/>      Easy bleeding denies. Bleeding problems denies. Fever denies.   <br/>   <span class="Underline">Genitourinary</span>: <br/>      Blood in the urine denies. Difficulty urinating denies. Frequent urination denies. Loss of urine with cough or laughter denies. Painful urination denies.   <br/>   <span class="Underline">Musculoskeletal</span>: <br/>      Back pain denies. Back problems denies. Joint stiffness denies. Leg cramps denies. Muscle aches denies.   <br/>   <span class="Underline">Peripheral Vascular</span>: <br/>      Absent pulses in feet denies. Absent pulses in hands denies. Blood clots in legs denies. Cold extremities denies. Pain / cramping in legs after exertion denies. Painful extremities denies.   <br/>   <span class="Underline">Skin</span>: <br/>      Changing moles denies. Discoloration denies. Dry skin denies. Hair changes denies. Itching denies.   <br/>   <span class="Underline">Neurologic</span>: <br/>      Balance difficulty denies. Difficulty speaking denies. Dizziness denies. Fainting denies. Gait abnormality denies. Headache denies.   <br/>   <span class="Underline">Psychiatric</span>: <br/>      Depressed mood denies. Difficulty sleeping denies. Loss of appetite denies. Mood disorder denies. Stressors denies.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> stent placed 2018Right eye 2017</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> heart attack 2008stroke 2018stroke 2019low blood sugar 2019fall 2019pneumonia [REDACTED] reg 03/2022ER Visit to [REDACTED] for headaches 05/2022ER [REDACTED] Bethesda hospt  for dialysis 05/2022Brandon 5/2022TGH Chest Pain 10/2023</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: alive. Mother: alive,  diagnosed with Essential hypertension. Paternal Grandfather: deceased. Paternal Grandmother: deceased. Maternal Grandfather: deceased. Maternal Grandmother: deceased. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Tobacco Use:</span> <br/>       Tobacco Use/Smoking <br/>         Tobacco use: <span class="italics">nonsmoker</span><br/>   <span class="Underline">Drugs/Alcohol:</span> <br/>       Drugs <br/>         Have you used drugs other than those for medical reasons in the past 12 months? <span class="italics">No</span><br/>      Alcohol Screen (Audit-C) <br/>         Did you have a drink containing alcohol in the past year? <span class="italics">Yes</span><br/>         How often did you have a drink containing alcohol in the past year? <span class="italics">Monthly or less (1 point)</span><br/>         How many drinks did you have on a typical day when you were drinking in the past year? <span class="italics">1 or 2 drinks (0 point)</span><br/>         How often did you have 6 or more drinks on one occasion in the past year? <span class="italics">Never (0 point)</span><br/>         Points <span class="italics">1</span><br/>         Interpretation <span class="italics">Negative</span><br/>      Caffeine <br/>         Intake: <span class="italics">1-2 cups per day</span><br/>      Do you smoke marijuana?: Denies. <br/>      Do you drink alcohol?: Socially. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingAlbuterol Sulfate (2.5 MG/3ML) 0.083% Nebulization Solution 3 mL as needed Inhalation Three times per day Albuterol Sulfate HFA 108 (90 Base) MCG/ACT Aerosol Solution 1 puff as needed Inhalation Every 6 hours Atorvastatin Calcium 80 MG Tablet 1 tablet Orally Once a day Envarsus XR 4 MG Tablet Extended Release 24 Hour one tablet Orally Daily EQ Aspirin Adult Low Dose 81 MG Tablet Delayed Release Take 1 tablet by mouth once daily   Fluticasone-Salmeterol 113-14 MCG/ACT Aerosol Powder Breath Activated 1 puff Inhalation Twice a day Folic Acid 1 MG Tablet 1 tablet Orally Once a day Gabapentin 300 MG Capsule Take 1 capsule by mouth once daily   Lantus SoloStar 100 UNIT/ML Solution Pen-injector 16-20 Units Subcutaneous Daily Latanoprost 0.005 % Solution 1 drop into affected eye in the evening Ophthalmic Once a day Lyrica 75 MG Capsule one capsule Orally twice a day Metoprolol Succinate 25 MG Capsule ER 24 Hour Sprinkle 1/2 tab Orally Twice a day , Notes to Pharmacist: *Reorder from Medispan for eRx and Interaction Alerts*Montelukast Sodium 10 MG Tablet one tablet Orally daily Myfortic 180 MG Tablet Delayed Release 1 tablet Orally Twice a day Nitroglycerin 0.4 MG Tablet Sublingual one tablet every 5 min. x 3 prn CP Sublingual As needed NovoLOG Mix 70/30 FlexPen (70-30) 100 UNIT/ML Suspension Pen-injector 10-20 units by sliding scale Subcutaneous twice a day Ondansetron 8 MG Tablet Disintegrating 1 tablet on the tongue and allow to dissolve Orally twice a day Pantoprazole Sodium 40 MG Tablet Delayed Release 1 tablet Orally Once a day predniSONE 2.5 MG Tablet TAKE 1 TABLET BY MOUTH ONCE DAILY Oral  ReliOn Pen Needles 31G X 8 MM Miscellaneous USE 1  THREE TIMES DAILY BEFORE MEAL(S)   traMADol HCl 50 MG Tablet 1 tablet as needed Orally Twice a day FOR NON-ACUTE PAIN True Metrix Blood Glucose Test - Strip as directed sq TID True metrix lancets lancet lancet 1 lancet dermally three times a day , Notes to Pharmacist: *Reorder from Medispan for eRx and Interaction Alerts*True Metrix Meter - Device as directed dermally TID Trulicity 1.5 MG/0.5ML Solution Pen-injector as directed Subcutaneous weekly Taking Albuterol Sulfate (2.5 MG/3ML) 0.083% Nebulization Solution 3 mL as needed Inhalation Three times per day Taking Albuterol Sulfate HFA 108 (90 Base) MCG/ACT Aerosol Solution 1 puff as needed Inhalation Every 6 hours Taking Atorvastatin Calcium 80 MG Tablet 1 tablet Orally Once a day Taking Envarsus XR 4 MG Tablet Extended Release 24 Hour one tablet Orally Daily Taking EQ Aspirin Adult Low Dose 81 MG Tablet Delayed Release Take 1 tablet by mouth once daily   Taking Fluticasone-Salmeterol 113-14 MCG/ACT Aerosol Powder Breath Activated 1 puff Inhalation Twice a day Taking Folic Acid 1 MG Tablet 1 tablet Orally Once a day Taking Gabapentin 300 MG Capsule Take 1 capsule by mouth once daily   Taking Lantus SoloStar 100 UNIT/ML Solution Pen-injector 16-20 Units Subcutaneous Daily Taking Latanoprost 0.005 % Solution 1 drop into affected eye in the evening Ophthalmic Once a day Taking Lyrica 75 MG Capsule one capsule Orally twice a day Taking Metoprolol Succinate 25 MG Capsule ER 24 Hour Sprinkle 1/2 tab Orally Twice a day , Notes to Pharmacist: *Reorder from Medispan for eRx and Interaction Alerts*Taking Montelukast Sodium 10 MG Tablet one tablet Orally daily Taking Myfortic 180 MG Tablet Delayed Release 1 tablet Orally Twice a day Taking Nitroglycerin 0.4 MG Tablet Sublingual one tablet every 5 min. x 3 prn CP Sublingual As needed Taking NovoLOG Mix 70/30 FlexPen (70-30) 100 UNIT/ML Suspension Pen-injector 10-20 units by sliding scale Subcutaneous twice a day Taking Ondansetron 8 MG Tablet Disintegrating 1 tablet on the tongue and allow to dissolve Orally twice a day Taking Pantoprazole Sodium 40 MG Tablet Delayed Release 1 tablet Orally Once a day Taking predniSONE 2.5 MG Tablet TAKE 1 TABLET BY MOUTH ONCE DAILY Oral  Taking ReliOn Pen Needles 31G X 8 MM Miscellaneous USE 1  THREE TIMES DAILY BEFORE MEAL(S)   Taking traMADol HCl 50 MG Tablet 1 tablet as needed Orally Twice a day FOR NON-ACUTE PAIN Taking True Metrix Blood Glucose Test - Strip as directed sq TID Taking True metrix lancets lancet lancet 1 lancet dermally three times a day , Notes to Pharmacist: *Reorder from Medispan for eRx and Interaction Alerts*Taking True Metrix Meter - Device as directed dermally TID Taking Trulicity 1.5 MG/0.5ML Solution Pen-injector as directed Subcutaneous weekly DiscontinuedGebauers Pain Ease - Aerosol as directed Externally  NIFEdipine ER 90 MG Tablet Extended Release 24 Hour 1 tablet on an empty stomach Orally Once a day Medication List reviewed and reconciled with the patientDiscontinued Gebauers Pain Ease - Aerosol as directed Externally  Discontinued NIFEdipine ER 90 MG Tablet Extended Release 24 Hour 1 tablet on an empty stomach Orally Once a day Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> Shellfish-derived ProductsIodineno[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 65.5 in, Wt: <span class="bold">244.8</span> lbs, Wt-kg: 111.04 kg, BMI: <span class="bold">40.11</span> Index, BP: Not Taken - Declined by Patient, HR: <span class="bold">92</span> /min, Temp: <span class="bold">97.0</span> F, RR: <span class="bold">16</span> /min, Oxygen sat %: <span class="bold">95</span> %, Pain scale: <span class="bold">6</span> 1-10, Body Surface Area: 2.26.<br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: well-appearing, in no acute distress , alert, and oriented . <br/>      Neck / thyroid: no lymphadenopathy, no thyromegaly, <span class="content_span">neck is supple, </span>. <br/>      Heart: regular rhythm, S1S2 normal, no S3 S4, regular rate and rhythm no clicks or rubs. <br/>      Chest: symmetric without any chest wall tenderness. <br/>      Lungs: nonlabored respirations, lungs are clear bilaterally without rales or rhonchi. <br/>      Abdomen: soft, non tender, not distended, soft with good bowel sounds, no masses . <br/>      Neurologic:  A &amp;O x 3, no new focal deficits, non-focal exam.. <br/>      Back: no spinal deformity or tenderness, no CVA tenderness. <br/>      Musculoskeletal: no new joint swellings or deformities , no swelling, redness, or warmth . <br/>      Skin: skin is warm and dry, with no rashes, good skin turgor and normal hair distribution. <br/>      Head: normocephalic, atraumatic. <br/>      Eyes: pupils equal, round, reactive to light and accommodation. <br/>      Ears: normal , auditory canal clear. <br/>      Nose: nares patent , no lesions. <br/>      Oral cavity: normal , mucosa moist. <br/>      Throat: no erythema , no exudate , . <br/>      Extremities: normal extremity with no clubbing, cyanosis or edema. <br/>      Peripheral pulses: normal 2+ arterial pulses. <br/>      Cardiovascular S1 and S2 regular, no gallop.. <br/>      Respiratory Clear to auscultation bilaterally. bilateral breath sounds present. <br/>      Gastrointestinal soft, non-tender/non-distended, no guarding or rigidity, bowel sounds present..    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease - I13.0 (Primary)   <content><span class="bold">Specify : </span>CKD stage 2</content>   2. CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min - N18.2   <content><span class="bold">Notes : </span>GFR 62</content>   3. Chronic diastolic congestive heart failure - I50.32   4. Coronary artery disease of native artery of native heart with stable angina pectoris - I25.118   5. PAF (paroxysmal atrial fibrillation) - I48.0   6. Type 2 diabetes mellitus with diabetic chronic kidney disease - E11.22   <content><span class="bold">Specify : </span>CKD stage 2</content>   7. Type 2 diabetes mellitus with hyperglycemia - E11.65   <content><span class="bold">Notes : </span>A1C 9.5</content>   8. Type 2 diabetes mellitus with other specified complication - E11.69   <content><span class="bold">Notes : </span>Hypercholesterolemia</content>   9. Hypercholesterolemia - E78.00   10. Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema - E11.319   11. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene - E11.51   12. Type 2 diabetes mellitus with diabetic polyneuropathy - E11.42   13. Type 2 diabetes mellitus with other circulatory complications - E11.59   14. Type 2 diabetes mellitus with diabetic nephropathy - E11.21   15. S/P kidney transplant - Z94.0   16. Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side - I69.354   17. Other thrombophilia - D68.69   18. Chronic obstructive pulmonary disease, unspecified COPD type - J44.9   19. Obstructive sleep apnea (adult) (pediatric) - G47.33   20. Opioid dependence with opioid-induced mood disorder - F11.24   21. Chronic GERD - K21.9   22. Moderate episode of recurrent major depressive disorder - F33.1   23. Non-radiographic axial spondyloarthritis of lumbosacral region - M45.A7   24. Lumbar spondylosis with myelopathy - M47.16   25. Environmental allergies - Z91.09   26. Immunodeficiency due to conditions classified elsewhere - D84.81   27. Continuous opioid dependence - F11.20   28. Stenosis of other vascular prosthetic devices, implants and grafts, initial encounter - T82.858A   29. Chronic pain syndrome - G89.4   30. Dependence on other enabling machines and devices - Z99.89   31. Long term (current) use of insulin - Z79.4   32. Morbid obesity - E66.01   33. Body mass index (BMI) of 38.0-38.9 in adult - Z68.38   </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or unspecified chronic kidney disease</span> <br/>Continue Metoprolol Succinate Capsule ER 24 Hour Sprinkle, 25 MG, 1/2 tab, Orally, Twice a day, Notes to Pharmacist: *Reorder from Medispan for eRx and Interaction Alerts*; Continue Nitroglycerin Tablet Sublingual, 0.4 MG, one tablet every 5 min. x 3 prn CP, Sublingual, As needed.  <br/>Notes: Controlling your high blood pressure is a lifelong commitment. You will always need to monitor your weight, make healthy food choices, exercise, learn to cope with stress, avoid smoking, and limit your alcohol intake. We will monitor your blood pressure going forward<br/>  </td></tr><tr><td/></tr><tr><td><span class="bold">2. CKD (chronic kidney disease) stage 2, GFR 60-89 ml/min</span> <br/>Notes:Avoid nephrotoxic agents.<br/>Monitor BP at home: keep a log and call &amp; call office if SBP&gt;140or DBP &gt;90.  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Chronic diastolic congestive heart failure</span> <br/>Notes: Patient to continue current medications and cardio recommendations/meds, monitor fluids: in and out.  Follow a low salt diet.  Increase ambulation and light exercise. <br/>Continue with current ACE/ARB and beta blocker. <br/>Patient instructed to call or return to clinic before appointment if condition worsens. VU  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Coronary artery disease of native artery of native heart with stable angina pectoris</span> <br/>Notes: Maintain good control of BP and Lipids, <br/>Monitor for symptoms.  </td></tr><tr><td/></tr><tr><td><span class="bold">5. PAF (paroxysmal atrial fibrillation)</span> <br/>Notes: No anticoagulants secondary to post-op status.  No clinical recurrence. Monitor s/s going forward. Cardiology followup.   </td></tr><tr><td/></tr><tr><td><span class="bold">6. Type 2 diabetes mellitus with diabetic chronic kidney disease</span> <br/>Continue Trulicity Solution Pen-injector, 1.5 MG/0.5ML, as directed, Subcutaneous, weekly, 30 days, 4, Refills 5; Continue Lantus SoloStar Solution Pen-injector, 100 UNIT/ML, 16-20 Units, Subcutaneous, Daily, 90 days, Refills 3; Continue NovoLOG Mix 70/30 FlexPen Suspension Pen-injector, (70-30) 100 UNIT/ML, 10-20 units by sliding scale, Subcutaneous, twice a day, 30 days, 5, Refills 11.  <br/>Notes:  Patient is followed by Endocrinology ([REDACTED]) to regulate his Diabetic Medications; last A1C was 11.6. <br/>Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml<br/>Lab ordered for A1C, GFR and urine proteins.  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Type 2 diabetes mellitus with other specified complication</span> <br/>Notes:  Patient is followed by Endocrinology ([REDACTED]) to regulate his Diabetic Medications; last A1C was 11.6.<br/>Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml<br/>Lab ordered for A1C, GFR and urine proteins.<br/>  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Hypercholesterolemia</span> <br/>Continue Atorvastatin Calcium Tablet, 80 MG, 1 tablet, Orally, Once a day, 90 days, 90, Refills 3.  <br/>Notes: Low cholesterol / high fiber diet. Monitor.  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Type 2 diabetes mellitus with unspecified diabetic retinopathy without macular edema</span> <br/>Continue Latanoprost Solution, 0.005 %, 1 drop into affected eye in the evening, Ophthalmic, Once a day, 30 days, 1, Refills 2.  <br/>Notes: Follows by Opthalmologist<br/>Monitor opthamologic signs and symptoms retinopathy present as a complication of diabetes.<br/><br/><br/>  </td></tr><tr><td/></tr><tr><td><span class="bold">10. Type 2 diabetes mellitus with diabetic peripheral angiopathy without gangrene</span> <br/>Notes:  Patient is followed by Endocrinology ([REDACTED]) to regulate his Diabetic Medications; last A1C was 11.6.<br/>Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml<br/>Lab ordered for A1C, GFR and urine proteins.  </td></tr><tr><td/></tr><tr><td><span class="bold">11. Type 2 diabetes mellitus with diabetic polyneuropathy</span> <br/>Notes: Monitor neurologic signs and symptoms going forward - neuropathy present as a complication of diabetes.  </td></tr><tr><td/></tr><tr><td><span class="bold">12. Type 2 diabetes mellitus with other circulatory complications</span> <br/>Notes: Followed by Endocrinologist  </td></tr><tr><td/></tr><tr><td><span class="bold">13. Type 2 diabetes mellitus with diabetic nephropathy</span> <br/>Notes: Followed by Nephrologist  </td></tr><tr><td/></tr><tr><td><span class="bold">14. S/P kidney transplant</span> <br/>Notes: Followed by Nephrologist  </td></tr><tr><td/></tr><tr><td><span class="bold">15. Hemiplegia and hemiparesis following cerebral infarction affecting left non-dominant side</span> <br/>Notes: Control comorbid conditions. <br/>Patient is to maintain normal blood pressure and blood glucose readings if diabetic. <br/>Stressed the importance of medication adherence.<br/>Follow a low fat diet and continue to monitor for signs and symptoms as discussed.  </td></tr><tr><td/></tr><tr><td><span class="bold">16. Other thrombophilia</span> <br/>Notes: linked to AFIB, continue aspirin therapy. <br/>WIll continue monitor   </td></tr><tr><td/></tr><tr><td><span class="bold">17. Chronic obstructive pulmonary disease, unspecified COPD type</span> <br/>Notes: If you smoke, quit.  Also avoid air pollution, chemical fumes, dust, and secondhand smoke. Do activities slowly and find simple ways to do daily activities, such as cooking or cleaning. Call your doctor if your symptoms are getting worse or if you have signs of an infection, such as fever.  </td></tr><tr><td/></tr><tr><td><span class="bold">18. Obstructive sleep apnea (adult) (pediatric)</span> <br/>Notes: Avoid sedatives/hypnotics and alcohol before going to bed. <br/>Stress importance of ongoing CPAP compliance.   </td></tr><tr><td/></tr><tr><td><span class="bold">19. Opioid dependence with opioid-induced mood disorder</span> <br/>Notes: Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high risk situations; Use has resulted in a reduction of recreational, social and or occupational activities; Note: Physical Dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/ or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy.<br/>  </td></tr><tr><td/></tr><tr><td><span class="bold">20. Chronic GERD</span> <br/>Continue Pantoprazole Sodium Tablet Delayed Release, 40 MG, 1 tablet, Orally, Once a day, 90 days, 90, Refills 1.  <br/>Notes: <content><content><content><span class="content_span">Watch alcohol, eating too close to bedtime, chocolate,caffeine, greasy, spicy, and acidic foods. Monitor symptoms.</span></content></content></content>  </td></tr><tr><td/></tr><tr><td><span class="bold">21. Moderate episode of recurrent major depressive disorder</span> <br/>Notes: Exercise regularly, eat healthy, and get plenty of sleep. Encourage yourself and be patient. Monitor Symptoms.  </td></tr><tr><td/></tr><tr><td><span class="bold">22. Non-radiographic axial spondyloarthritis of lumbosacral region</span> <br/>Notes: Reviewed appropriate OTC's, massage, and ice or heat as needed. Correct posture when sitting and during activities; Stay active and do not forget to stretch. Monitor Symptoms.  </td></tr><tr><td/></tr><tr><td><span class="bold">23. Lumbar spondylosis with myelopathy</span> <br/>Notes: Reviewed appropriate OTC's, massage, and ice or heat as needed. Correct posture when sitting and during activities; Stay active and do not forget to stretch. Monitor Symptoms.  </td></tr><tr><td/></tr><tr><td><span class="bold">24. Environmental allergies</span> <br/>Continue Montelukast Sodium Tablet, 10 MG, one tablet, Orally, daily, 90 days, 90, Refills 3.  <br/>Notes: <content><content><content><span class="content_span">Avoid things you are allergic to by: keeping windows closedduring high-pollen season, showering before bed to wash off allergens andusing dust and mite-proof bedding and mattress covers. Monitor symptoms.</span></content></content></content>  </td></tr><tr><td/></tr><tr><td><span class="bold">25. Immunodeficiency due to conditions classified elsewhere</span> <br/>Notes: <content><content><content><content><span class="content_span">Chronic disease present - High risk patient. Monitorclosely for occult infections going forward.  </span></content></content></content></content>  </td></tr><tr><td/></tr><tr><td><span class="bold">26. Continuous opioid dependence</span> <br/>Notes: Positive responses to Dependence Assessment: Use of substance over longer period of time than intended; Persistent or unsuccessful efforts to decrease use; Use of substance in high risk situations; Use has resulted in a reduction of recreational, social and or occupational activities; Note: Physical Dependence can occur after prolonged use of therapeutic doses. In general, medication should be discontinued slowly to minimize symptoms such as: sleep disturbances, elevated anxiety, seizures and/ or hallucinations. PDMP (Eforce) has been monitored for compliance to prescribed therapy.  </td></tr><tr><td/></tr><tr><td><span class="bold">27. Stenosis of other vascular prosthetic devices, implants and grafts, initial encounter</span> <br/>Notes: Monitor for changes  </td></tr><tr><td/></tr><tr><td><span class="bold">28. Chronic pain syndrome</span> <br/>Notes: Followed by PM  </td></tr><tr><td/></tr><tr><td><span class="bold">29. Dependence on other enabling machines and devices</span> <br/>Notes: Safety precautions discussed and advised the patient to be aware of their surroundings  </td></tr><tr><td/></tr><tr><td><span class="bold">30. Long term (current) use of insulin</span> <br/>Notes: Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml<br/><br/>  </td></tr><tr><td/></tr><tr><td><span class="bold">31. Morbid obesity</span> <br/>Notes: Encouraged and stressed importance of diet and physical activity to improve BMI and overall health.  Discussed obtaining goal BMI through diet and exercise program.  </td></tr><tr><td/></tr><tr><td><span class="bold">32. Body mass index (BMI) of 38.0-38.9 in adult</span> <br/>Notes: Encouraged and stressed importance of diet and physical activity to improve BMI and overall health.  Discussed obtaining goal BMI through diet and exercise program.  </td></tr><tr><td/></tr><tr><td><span class="bold">33. Others </span> <br/>Notes: Advised to keep appt as scheduled <br/><br/><br/>  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 94760 MEASURE BLOOD OXYGEN LEVEL1159F MED LIST DOCD IN RCRD1160F RVW MEDS BY RX/DR IN RCRDG8427 DOC MEDS VERIFIED W/PT OR RE1125F AMNT PAIN NOTED PAIN PRSNTG8417 BMI &gt;=30 CALCUATE W/FOLLOWUP</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  Your Annual Wellness Plan: <br/>       BMI, height, and weight: <br/>          My BMI, height, and weight were taken on: <span class="italics">[REDACTED] Recommended weight loss, well-balanced diet and daily exercise; increase fluids, take your medication as prescribed, and walk at least 30 minutes a day for 5 days; wear comfortable walking shoes and walk at your own pace. VU</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 4 Weeks (Reason: Labs 1 week before office visit)</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>94760 MEASURE BLOOD OXYGEN LEVEL. <br/>1159F MED LIST DOCD IN RCRD. <br/>1160F RVW MEDS BY RX/DR IN RCRD. <br/>G8427 DOC MEDS VERIFIED W/PT OR RE. <br/>1125F AMNT PAIN NOTED PAIN PRSNT. <br/>G8417 BMI &gt;=30 CALCUATE W/FOLLOWUP. </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top"/></tr><tr><td/></tr><tr><td/></tr><tr><td valign="top">Electronically signed by [REDACTED] , ARNP, APRN9177415  on [REDACTED] 09:26 AM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> [REDACTED], ARNP, FNP-C</td><td align="right"><span class="bold">Date: </span>[REDACTED]</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: [REDACTED] 04:09 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id11" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>HPI (History of Present Illness)</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td>[REDACTED]</td><td>Patient is here for</td><td colspan="2"><p>[REDACTED] male who comes into the office accompanied by mother for a f/up visit and monitoring. Pt does not know all his medications; mother in charge of medications. Mother in the room, but most of the time she is on her phone and is not paying attention to her son's medical care. HTN; on Metoprolol 25mg 1/2 tab BID, Nitroglycerine 0.4mg sublingual prn. Patient seen by Cardiologist [REDACTED]; pt stated "the Dr did an EKG at the office and he told me that my heart is good"; next f/up [REDACTED]. Noted B/P [REDACTED] 100/60; pt stated "my B/P at home is usually low; this morning it was 92/71 after I took my medication; it usually runns low; that is the reason sometimes I do not take the B/P medication" Patient did not bring his B/P log. Advised to keep a log and to bring it next office Patient is not on any Cardiac distress, denies any SOB, chest pain or chest pressure. </p><p>Recommended to Monitor BP at home: keep a log and call &amp; call office if SBP&gt;140</p><p>or DBP  greater than 90.</p><p>CAD s/p MI/ STENT; denies any SOB, CP, or chest pressure PAF; on Metoprolol Succ 25mg, Low Na diet CVA WITH LEFT SIDED WEAKNESS; Instructed on fall precautions and on change of positions ESRD; S/P RENAL TRANSPLANT, patient continues to follow up regularly with Nephrologist at TGH Transplant Medicine. Next appt on [REDACTED]. HYPERCHOLESTEROLEMIA; pt on Atorvastatin 80mg OSA monitor for change GERD; avoid irritant foods and continue Tx T2DM; pt is followed by Endocrinology ([REDACTED]) to regulate his Diabetic Medications; last A1C was 11.6. Patient on Lantus 35U BID, and Novalog 20-30 BID, and Trulicity 1.5mg/0.5ml. Patient has f/up appt [REDACTED]. Chronic Lower back pain; pt stated " I saw PM Dr last week and he gave me 6 injections to my lower back area" Patient has not done any of his labs </p><p>Patient</p><p>medication has been reviewed and does not report any side effects. </p><p>Patients current medication were reviewed, and</p><p>Refills given as in chart., </p><p>Patient does not complain of any shortness of</p><p>breath or chest pain.</p></td></tr></tbody></table><br/><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="25">General Examination</td><td>General appearance:</td><td colspan="2">well-appearing, in no acute distress , alert, and oriented </td></tr><tr><td>Head:</td><td colspan="2">normocephalic, atraumatic</td></tr><tr><td>Eyes:</td><td colspan="2">pupils equal, round, reactive to light and accommodation</td></tr><tr><td>Ears:</td><td colspan="2">normal , auditory canal clear</td></tr><tr><td>Nose:</td><td colspan="2">nares patent , no lesions</td></tr><tr><td>Throat:</td><td colspan="2">no erythema , no exudate ,</td></tr><tr><td>Neck / thyroid:</td><td colspan="2">no lymphadenopathy, no thyromegaly, neck is supple, </td></tr><tr><td>Heart:</td><td colspan="2">regular rhythm, S1S2 normal, no S3 S4, regular rate and rhythm no clicks or rubs</td></tr><tr><td>Chest:</td><td colspan="2">symmetric without any chest wall tenderness</td></tr><tr><td>Lungs:</td><td colspan="2">nonlabored respirations, lungs are clear bilaterally without rales or rhonchi</td></tr><tr><td>Abdomen:</td><td colspan="2">soft, non tender, not distended, soft with good bowel sounds, no masses </td></tr><tr><td>Neurologic:</td><td colspan="2"> A &amp;O x 3, no new focal deficits, non-focal exam.</td></tr><tr><td>Skin:</td><td colspan="2">skin is warm and dry, with no rashes, good skin turgor and normal hair distribution</td></tr><tr><td>Extremities:</td><td colspan="2">normal extremity with no clubbing, cyanosis or edema</td></tr><tr><td>Peripheral pulses:</td><td colspan="2">normal 2+ arterial pulses</td></tr><tr><td>Back:</td><td colspan="2">no spinal deformity or tenderness, no CVA tenderness</td></tr><tr><td>Breasts:</td><td colspan="2"/></tr><tr><td>Musculoskeletal:</td><td colspan="2">no new joint swellings or deformities , no swelling, redness, or warmth</td></tr><tr><td>Oral cavity:</td><td colspan="2">normal , mucosa moist</td></tr><tr><td>HEENT</td><td colspan="2"/></tr><tr><td>Cardiovascular</td><td colspan="2">S1 and S2 regular, no gallop.</td></tr><tr><td>Respiratory</td><td colspan="2">Clear to auscultation bilaterally. bilateral breath sounds present</td></tr><tr><td>Gastrointestinal</td><td colspan="2">soft, non-tender/non-distended, no guarding or rigidity, bowel sounds present.</td></tr><tr><td>Neurological Exam</td><td colspan="2"/></tr><tr><td>Genitourinary</td><td colspan="2"/></tr></tbody></table><br/></li></ul></div><br/><br/>
</body></html>